FindTrial
Sign In

Hypovolemic phlebotomy with lower central venous pressure apply to hepactomy of cancer

Hypovolemic phlebotomy with lower central venous pressure apply to hepactomy of cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017349
Enrollment
Unknown
Registered
2018-07-25
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Case series:Hypovolemic phlebotomy

Sponsors

Department of anesthesiology, Affiliated Tumor Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years, ASA I ~ II, cardiac function grade I ~ II; Without hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, vascular disease;No obvious abnormal preoperative heart, liver and kidney function

Exclusion criteria

Exclusion criteria: Intraoperative use of vasoactive drugs cannot maintain the MAP or 60 MMHG, temporary change operation method to laparoscopic surgery (laparotomy); Center venipuncture failure; Record the data loss caused incomplete.

Design outcomes

Primary

MeasureTime frame
central venous pressure;—

Countries

China

Contacts

Public ContactJiazhen Huang

Affiliated Tumor Hospital of Guangxi Medical University

1163838486@qq.com+86 15289642948

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026